2019 ACR/ARP Annual Meeting

November 8-13, 2019. Atlanta, GA.

View by Number View by Title View Sessions

View by Date

Tuesday, November 12, 2019

2:30PM-4:00PM: Abstract Number: 2748

Cracking a Novel Profibrotic Molecular Mechanism: lncRNA H19X and DDIT4L Crosstalk

5T095: Systemic Sclerosis & Related Disorder – Basic Science (2744–2749)

2:30PM-4:00PM: Abstract Number: 2750

Development and Preliminary Validation of a Novel Lung Ultrasound Interpretation Criteria for the Detection of Interstitial Lung Disease in Patients with Systemic Sclerosis

5T089: Imaging of Rheumatic Diseases II (2750–2755)

2:30PM-4:00PM: Abstract Number: 2738

Differential Methylation of Peripheral Blood Adaptive Immune Cells in Individuals at High Risk for RA and with Early RA Compared with Controls Identifies Pathways Important in Transition to Arthritis

5T088: Genetics, Genomics & Proteomics (2738–2743)

2:30PM-4:00PM: Abstract Number: 2746

Dimethyl Fumarate Ameliorates the GATA6 Deficiency-Induced Pulmonary Hypertension by Normalizing Oxidative and ER Stress

5T095: Systemic Sclerosis & Related Disorder – Basic Science (2744–2749)

2:30PM-4:00PM: Abstract Number: 2799

Does Early Anterior Cruciate Ligament Reconstruction Prevent Further Meniscal Damage? Secondary Analysis of a Randomized Controlled Trial

5T098: Orthopedics, Low Back Pain & Rehabilitation (2798–2803)

2:30PM-4:00PM: Abstract Number: 2803

Efficacy of a 3-Month Wearable-enabled Physical Activity Counselling Program for People with Knee Osteoarthritis

5T098: Orthopedics, Low Back Pain & Rehabilitation (2798–2803)

2:30PM-4:00PM: Abstract Number: 2797

Exploring Possible Predictors of Physical Activity in Knee Replacement Patients

5T101: Clinical Aspects & Outcomes Research (2792–2797)

2:30PM-4:00PM: Abstract Number: 2800

Five Year Structural Changes in Patients with Meniscal Tear and Osteoarthritis from an RCT of Arthroscopic Partial Meniscectomy vs. Physical Therapy

5T098: Orthopedics, Low Back Pain & Rehabilitation (2798–2803)

2:30PM-4:00PM: Abstract Number: 2737

HIF-1α and miR-210 Differential and Lineage-specific Expression in Systemic Lupus Erythematosus

5T087: Edmond L. Dubois, MD Memorial Lecture: SLE – Basic Science (2733–2737)

2:30PM-4:00PM: Abstract Number: 2802

High Intensity Interval Training for Knee Osteoarthritis: A Pilot Study

5T098: Orthopedics, Low Back Pain & Rehabilitation (2798–2803)

2:30PM-4:00PM: Abstract Number: 2779

Higher Disease Activity Is Associated with More Spinal Radiographic Progression in Patients with Axial Spondyloarthritis Independently of Prior Exposure to TNF Inhibitors

5T094: Spondyloarthritis Including Psoriatic Arthritis – Clinical V: Axial Spondyloarthritis Clinical Studies (2774–2779)

2:30PM-4:00PM: Abstract Number: 2783

Hydroxychloroquine Blood Levels and Risk of Thrombotic Events in Systemic Lupus Erythematous

5T093: SLE – Clinical V: Emerging Knowledge of Current Treatments (2780–2785)

2:30PM-4:00PM: Abstract Number: 2747

Identification of Naturally Presented Peptides of the Autoantigen Topoisomerase-I Reveals a Common Pathogenic Mechanism in Patients with Systemic Sclerosis

5T095: Systemic Sclerosis & Related Disorder – Basic Science (2744–2749)

2:30PM-4:00PM: Abstract Number: 2780

Identification of SLE Subgroups at Risk for Poor Outcomes After Hydroxychloroquine Taper or Discontinuation

5T093: SLE – Clinical V: Emerging Knowledge of Current Treatments (2780–2785)

2:30PM-4:00PM: Abstract Number: 2745

Iguratimod Treated Scleroderma with Interrupted Egr1/TGF-β Loop

5T095: Systemic Sclerosis & Related Disorder – Basic Science (2744–2749)

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].